Sagona Europe Equity SCSp focuses on innovative businesses based in Europe at seed and early stage with modern approaches to established leaders expanding into new markets. Sagona Europe Equity SCSp aims to invest in companies that address economic needs in potential new markets created by technological advancements.
Sagona Europe Equity SCSp seeks device or technology which create a new treatment modality or represent a substantial improvement. The companies must have a business model that provides a sustainable advantage, the potential to serve a significant addressable global market with a robust intellectual property protection resulting in potential breakthrough technology and must fit an area of strategic need for potential acquirers.
Global innovation such as artificial intelligence, nanotechnology, fintech, blockchain, SaaS, new media and communication.
Medtech companies involved especially in medical devices industry, instrumentation, diagnostics, imaging, healthcare IT, robotics, artificial intelligence (deep/machine learning), real-time disease monitoring, patient treatment (remote consultation and follow-up) and efficiency of the patient’s care path.
Sustainability & Greentech
Companies resepctively involved in smart cities, used water treatment, waste management and smart farming, renewable energies and any innovation to sustain environment and ecology.
Purpose-driven companies with modern approaches to established leaders expanding into new markets.
5 - 7 years
Series A / B
5 - 7 years
Equity and/or debt